278 related articles for article (PubMed ID: 25132062)
21. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
[TBL] [Abstract][Full Text] [Related]
23. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.
Blanc V; Riordan JD; Soleymanjahi S; Nadeau JH; Nalbantoglu I; Xie Y; Molitor EA; Madison BB; Brunt EM; Mills JC; Rubin DC; Ng IO; Ha Y; Roberts LR; Davidson NO
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33445170
[TBL] [Abstract][Full Text] [Related]
24. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA
Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.
Webster NJG; Kumar D; Wu P
Sci Rep; 2024 Jan; 14(1):2500. PubMed ID: 38291075
[TBL] [Abstract][Full Text] [Related]
27. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
30. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
[TBL] [Abstract][Full Text] [Related]
31. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
32. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.
Liang Y; Feng Y; Zong M; Wei XF; Lee J; Feng Y; Li H; Yang GS; Wu ZJ; Fu XD; Feng GS
Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte Wnts Are Dispensable During Diethylnitrosamine and Carbon Tetrachloride-Induced Injury and Hepatocellular Cancer.
Preziosi M; Poddar M; Singh S; Monga SP
Gene Expr; 2018 Aug; 18(3):209-219. PubMed ID: 29519268
[TBL] [Abstract][Full Text] [Related]
34. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
35. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
[TBL] [Abstract][Full Text] [Related]
36. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
37. A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.
Ajiro M; Jia R; Yang Y; Zhu J; Zheng ZM
Nucleic Acids Res; 2016 Feb; 44(4):1854-70. PubMed ID: 26704980
[TBL] [Abstract][Full Text] [Related]
38. Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression.
Yan Q; Fang X; Liu X; Guo S; Chen S; Luo M; Lan P; Guan XY
Adv Sci (Weinh); 2024 Jan; 11(1):e2305653. PubMed ID: 37985644
[TBL] [Abstract][Full Text] [Related]
39. Splicing Regulator p54
Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
[TBL] [Abstract][Full Text] [Related]
40. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
